The pathology of rainbow trout lenses incubated in various media and at various temperatures was examined by electron microscopy. After incubation at 0°C for 5 h, no changes were observed in transparency and cytology. Irreversible warm cataract occurred at 37 °C, which corresponds to the body temperature of mammals. The degree of turbidity increased depending on incubation time. The ultrastructure of warm cataract in short-term incubation was characterized by the appearance of dense substances in the epithelium and swelling of the lens fibers. When the incubation time was prolonged up to 3 h, the turbidity increased and cellular disorders became severe. The volume of the dense substances increased also. A slight but detectable haziness of the lens was observed after incubation with calcium-free medium. Pathological findings in this case consisted of disorders of the intracellular membrane system in the epithelium and swelling of the lens fibers. These results suggest that the rainbow trout lens has a lower optimum temperature compared to the mammalian lens but requires the same Ca2+ concentration.

Keywords:
Rainbow trout lens, Lens incubation, Warm cataract, Ca2+-free medium, Pathology
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.